Michael J. LaBarre - 01 Jul 2021 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role: SVP, Chief Technical Officer
Signature: /s/ James R. Oehler as attorney-in-fact for Michael J. LaBarre
Issuer symbol: HALO
Transactions as of: 01 Jul 2021
Net transactions value: -$1,578,252
Form type: 4
Filing time: 06 Jul 2021, 17:19:31 UTC
Next filing: 15 Jul 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HALO	Common Stock	Options Exercise	$264,063	+40,315	+30%	$6.55^*	174,426	01 Jul 2021	Direct
transaction	HALO	Common Stock	Sale	$1,842,315	-40,315	-23%	$45.70	134,111	01 Jul 2021	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HALO	Option to Purchase Common Stock	Options Exercise	$0	-40,315	-73%	$0.000000	14,685	01 Jul 2021	Common Stock	40,315	$6.55	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This disposition was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2	Represents a weighted average sales price per share. These shares were sold at prices ranging from $45.20 to $46.06. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
F3	This option was granted on February 4, 2013 and vested one-fourth on the first anniversary of such date and then 1/48th monthly thereafter.